Factory 99% Vancomycin Powder CAS 1404-90-6 Chemical Intermediate Antibacterial Vancomycin

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A527
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Vancomycin
• CAS: 1404-90-6
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Antibacterial
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Vancomycin
Appearance	White Powder
CAS NO.	1404-90-6
Molecular Formula	C66H75Cl2N9O24
Storage	Keep in a cool, dry, dark location

 

Vancomycin is a broad-spectrum antibiotic primarily used to treat serious bacterial infections that are resistant to other antibiotics.

 

1. Treatment of Resistant Infections: Vancomycin is employed in the treatment of infections caused by Gram-positive bacteria, particularly those resistant to other antibiotics such as methicillin-resistant Staphylococcus aureus (MRSA).
2. Alternative Therapy: It serves as an alternative therapy for patients who are allergic to penicillin and require treatment for infections caused by susceptible organisms.
3. Prophylactic Use: In some cases, vancomycin may be used prophylactically to prevent infections in high-risk patients, such as those undergoing surgical procedures or with compromised immune systems.

1. Bacterial Cell Wall Inhibition: Vancomycin functions by inhibiting the synthesis of the bacterial cell wall, specifically targeting the peptidoglycan component. This leads to cell wall weakening and eventual cell lysis, thereby eliminating the bacteria.
2. Broad-Spectrum Activity: It demonstrates activity against a wide range of Gram-positive bacteria, including Staphylococcus, Streptococcus, and Enterococcus species.
3. Lack of Cross-Resistance: Vancomycin is notable for its lack of cross-resistance with other antibiotics, meaning bacteria resistant to other drugs may still be susceptible to vancomycin.